SCRIFFIGNANO, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 848
EU - Europa 820
AS - Asia 307
AF - Africa 129
SA - Sud America 21
OC - Oceania 1
Totale 2.126
Nazione #
US - Stati Uniti d'America 830
IE - Irlanda 324
SG - Singapore 175
CI - Costa d'Avorio 128
RU - Federazione Russa 105
FI - Finlandia 78
CN - Cina 75
DE - Germania 60
UA - Ucraina 51
IT - Italia 47
HK - Hong Kong 40
GB - Regno Unito 38
AT - Austria 28
SE - Svezia 25
FR - Francia 22
BR - Brasile 17
BE - Belgio 15
CA - Canada 15
LT - Lituania 9
NL - Olanda 6
IN - India 5
ES - Italia 3
CZ - Repubblica Ceca 2
MY - Malesia 2
NO - Norvegia 2
TR - Turchia 2
VN - Vietnam 2
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
IL - Israele 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 2.126
Città #
Dublin 324
Chandler 184
Abidjan 128
Jacksonville 112
Singapore 77
Helsinki 76
Ann Arbor 45
Hong Kong 39
Vienna 26
Ashburn 24
Wilmington 24
Princeton 23
San Mateo 23
Boardman 19
Dearborn 19
Los Angeles 18
Beijing 17
Brussels 15
Rome 15
Dallas 12
Frankfurt am Main 11
Redwood City 11
London 8
Manchester 8
Woodbridge 8
Nanjing 7
New York 7
Ottawa 7
Guangzhou 6
Shanghai 6
Esslingen am Neckar 5
Falkenstein 5
Toronto 5
Amsterdam 4
Council Bluffs 4
Fleet 4
The Dalles 4
Ariccia 3
Borås 3
Hefei 3
Milan 3
Moscow 3
Newark 3
Ningbo 3
Tianjin 3
Assago 2
Avignon 2
Cernusco sul Naviglio 2
Changsha 2
Eden Prairie 2
Ho Chi Minh City 2
Houston 2
Ilmenau 2
Jinan 2
João Pessoa 2
Lappeenranta 2
Letchworth Garden City 2
Mountain View 2
Newcastle-under-Lyme 2
Olomouc 2
Oslo 2
Quzhou 2
San Bernardino 2
Santa Clara 2
Shenyang 2
Simi Valley 2
Stockport 2
São Paulo 2
Zhengzhou 2
Almaty 1
Auburn 1
Auckland 1
Bangalore 1
Baotou 1
Boston 1
Bratislava 1
Buenos Aires 1
Campobasso 1
Carpi 1
Casablanca 1
Cazzago San Martino 1
Chongqing 1
Cuiabá 1
Curitiba 1
Dhaka 1
Düsseldorf 1
Forest City 1
Fort Worth 1
Foshan 1
Gravina di Catania 1
Grottaglie 1
Handan 1
Hyderabad 1
Jaipur 1
Jinzhong 1
Kharkov 1
Kuala Lumpur 1
Kunming 1
Lanzhou 1
Leawood 1
Totale 1.433
Nome #
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 115
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 101
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 91
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 89
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 87
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 86
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 84
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 80
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 76
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 76
Role of comorbidities in spondyloarthritis including psoriatic arthritis 71
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 67
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 62
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 62
Dr. Lubrano, et al reply 61
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 60
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 58
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 55
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 54
Residual disease activity and associated factors in Psoriatic Arthritis 50
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 47
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 44
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 44
Rheumatology Care in the Face of COVID-19 44
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 37
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 36
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 34
Psoriatic Arthritis in Males and Females: Differences and Similarities 33
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 32
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 32
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 30
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 27
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 26
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 25
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 25
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 22
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 19
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 19
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis 19
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 19
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 18
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 15
Il laboratorio in Reumatologia 14
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 13
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 13
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 9
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 8
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 6
Women in rheumatology: major contributions and key discoveries of the twentieth century 4
Totale 2.199
Categoria #
all - tutte 15.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 4 16
2020/2021186 7 18 0 29 31 9 29 10 23 6 24 0
2021/2022116 7 23 0 3 4 0 2 11 21 32 2 11
2022/2023752 88 30 16 58 18 50 8 40 379 37 19 9
2023/2024243 59 40 24 5 12 13 2 21 9 13 15 30
2024/2025664 152 36 102 13 150 21 14 41 98 37 0 0
Totale 2.199